- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2023
-
A human monoclonal antibody bivalently binding two different epitopes in streptococcal M protein mediates immune function
(2023)
In EMBO Molecular Medicine
15(2).
p.1-21
- Contribution to journal › Article
-
IdeS, a secreted proteinase of Streptococcus pyogenes, is bound to a nuclease at the bacterial surface where it inactivates opsonizing IgG antibodies
(2023)
In Journal of Biological Chemistry
299(11).
p.1-16
- Contribution to journal › Article
- 2021
-
Suggested treatment of serious complications to COVID-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme
(2021)
In Journal of Thrombosis and Haemostasis
19(9).
p.2363-2364
- Contribution to journal › Letter
-
Streptococcal protein SIC activates monocytes and induces inflammation
(2021)
In iScience
24(4).
- Contribution to journal › Article
-
Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine : COMMENT from Gruel et al.: RESPONSE from Kahn et al.
(2021)
In Journal of Thrombosis and Haemostasis
19(10).
p.2633-2633
- Contribution to journal › Letter
-
Vaccine-induced, but not natural immunity, against the Streptococcal inhibitor of complement protects against invasive disease
(2021)
In npj Vaccines
6.
- Contribution to journal › Article
- 2020
-
Finegoldia magna, an Anaerobic Gram-Positive Bacterium of the Normal Human Microbiota, Induces Inflammation by Activating Neutrophils
(2020)
In Frontiers in Microbiology
11.
- Contribution to journal › Article
- 2019
-
A quantitative Streptococcus pyogenes-human protein-protein interaction map reveals localization of opsonizing antibodies
(2019)
In Nature Communications
10(1).
p.2727-2727
- Contribution to journal › Article
-
The molecular basis of human igg-mediated enhancement of C4b-binding protein recruitment to group a streptococcus
(2019)
In Frontiers in Immunology
10(JUN).
- Contribution to journal › Article
- 2018
-
Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients
(2018)
In American Journal of Transplantation
18(11).
p.2752-2762
- Contribution to journal › Article